NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 00517-2710-25 — Calcium chloride injection, intravenousAI (178 hospitals, 29,947–30,298 samples)
• NDC 60687-0206-01 — Diltiazem extended-release 180 mg capsulesAI (758 hospitals, 29,565–30,294 samples)
• NDC 68462-0534-35 — Tacrolimus 0.1% topical ointmentAI (154 hospitals, 29,374–30,292 samples)
• NDC 16571-0754-53 — Neomycin, bacitracin and polymyxin B eye ointmentAI (256 hospitals, 29,374–30,292 samples)
• NDC 47335-0779-91 — Azelastine nasal spray, 137 mcgAI (171 hospitals, 29,374–30,292 samples)
• NDC 52817-0611-04 — Clonidine 0.2 mg/24 hr weekly transdermal patchAI (271 hospitals, 29,374–30,292 samples)
• NDC 61314-0672-25 — Gatifloxacin 0.5% eye dropsAI (238 hospitals, 29,374–30,292 samples)
• NDC 00574-7090-12 — Hydrocortisone 25 mg rectal suppositoryAI (413 hospitals, 29,444–30,290 samples)
• NDC 60687-0446-01 — Ibuprofen 400 mg tabletAI (423 hospitals, 29,177–30,284 samples)
• NDC 68462-0184-49 — Metronidazole vaginal gelAI (110 hospitals, 29,372–30,272 samples)
• NDC 16714-0496-02 — Clotrimazole and betamethasone topical creamAI (136 hospitals, 29,372–30,272 samples)
• NDC 16714-0955-02 — KETOCONAZOLE 2 % TOPICAL CREAMAI (99 hospitals, 29,372–30,272 samples)
• NDC 16714-0246-01 — Clindamycin 1% topical lotionAI (56 hospitals, 29,372–30,272 samples)
• NDC 38779-0598-05 — Potassium iodide and iodine topical solutionAI (117 hospitals, 29,372–30,272 samples)
• NDC 60758-0801-10 — Timolol eye drops 0.5%AI (168 hospitals, 29,372–30,272 samples)
• NDC 63629-8847-01 — Hydrocortisone 2.5% topical cream with applicatorAI (98 hospitals, 29,372–30,272 samples)
• NDC 81033-0512-50 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (146 hospitals, 29,372–30,272 samples)
• NDC 00168-0265-50 — Betamethasone topical creamAI (36 hospitals, 29,372–30,272 samples)
• NDC 00713-0676-53 — TRIAMCINOLONE ACETONIDE 0.1 % LOTIONAI (200 hospitals, 29,372–30,272 samples)
• NDC 45802-0144-64 — Hydrocortisone and pramoxine creamAI (314 hospitals, 29,372–30,272 samples)
• NDC 72266-0197-01 — Dorzolamide 2% eye dropsAI (356 hospitals, 29,372–30,272 samples)
• NDC 00093-4061-06 — Formoterol fumarate 20 mcg nebulizer solutionAI (49 hospitals, 29,372–30,272 samples)
• NDC 49502-0806-93 — Revefenacin inhalation solutionAI (197 hospitals, 29,372–30,272 samples)
• NDC 16714-0037-01 — Ephedrine sulfate injection, 50 mg/mL vialAI (50 hospitals, 29,372–30,272 samples)
• NDC 23155-0160-31 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (62 hospitals, 29,372–30,272 samples)
• NDC 00168-0056-15 — BETAMETHASONE DIPROPIONATE 0.05 % TOPICAL OINTMENTAI (211 hospitals, 29,372–30,272 samples)
• NDC 00832-1410-03 — Moxifloxacin eye dropsAI (166 hospitals, 29,372–30,272 samples)
• NDC 16714-0037-10 — Ephedrine sulfate injection, 50 mg per mLAI (91 hospitals, 29,372–30,272 samples)
• NDC 55150-0286-10 — CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTIONAI (72 hospitals, 29,372–30,272 samples)
• NDC 61314-0126-10 — Ketorolac eye dropsAI (179 hospitals, 29,372–30,272 samples)
• NDC 00713-0632-31 — FLUTICASONE PROPIONATE 0.005 % TOPICAL OINTMENTAI (30 hospitals, 29,372–30,272 samples)
• NDC 64679-0465-50 — Lidocaine 4% mucosal solutionAI (113 hospitals, 29,372–30,272 samples)
• NDC 64679-0465-51 — Lidocaine 4% mucosal solutionAI (153 hospitals, 29,372–30,272 samples)
• NDC 70710-1534-06 — Cisatracurium 10 mg/mL intravenous solutionAI (47 hospitals, 29,372–30,272 samples)
• NDC 72578-0084-02 — Clindamycin topical solution 1% for skin useAI (52 hospitals, 29,372–30,272 samples)
• NDC 00280-0065-01 — Azelastine nasal spray (0.15%)AI (33 hospitals, 29,372–30,272 samples)
• NDC 72578-0093-06 — BETAMETHASONE DIPROPIONATE 0.05 % TOPICAL OINTMENTAI (54 hospitals, 29,372–30,272 samples)
• NDC 64980-0515-01 — OFLOXACIN 0.3 % EYE DROPSAI (112 hospitals, 29,372–30,272 samples)
• NDC 70710-1534-01 — Cisatracurium injection for intravenous useAI (50 hospitals, 29,372–30,272 samples)
• NDC 55150-0286-01 — Cisatracurium 2 mg/mL injection solutionAI (55 hospitals, 29,372–30,272 samples)
• NDC 59762-0131-00 — SILVER SULFADIAZINE 1 % TOPICAL CREAMAI (46 hospitals, 29,372–30,272 samples)
• NDC 65162-0995-04 — Estradiol skin patch, twice weekly, 0.075 mg per dayAI (56 hospitals, 29,372–30,272 samples)
• NDC 23155-0160-41 — ETOMIDATE 2 MG/ML INTRAVENOUS SOLUTIONAI (63 hospitals, 29,372–30,272 samples)
• NDC 00378-8085-15 — TRETINOIN 0.01 % TOPICAL GELAI (52 hospitals, 29,372–30,272 samples)
• NDC 69238-1534-03 — FLUOCINONIDE 0.05 % TOPICAL CREAMAI (101 hospitals, 29,372–30,272 samples)
• NDC 51672-1301-04 — AMMONIUM LACTATE 12 % TOPICAL CREAMAI (58 hospitals, 29,372–30,272 samples)
• NDC 00121-0992-95 — LACOSAMIDE 10 MG/ML ORAL SOLUTIONAI (43 hospitals, 29,372–30,272 samples)
• NDC 66887-0001-01 — Testosterone 1% transdermal gel, 50 mg per 5 gAI (29 hospitals, 29,372–30,272 samples)
• NDC 62135-0822-84 — Budesonide 0.25 mg/2 mL nebulizer suspensionAI (26 hospitals, 29,372–30,272 samples)
• NDC 41167-0571-00 — DICLOFENAC 1 % TOPICAL GELAI (31 hospitals, 29,372–30,272 samples)